Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art

RSS



app icon

iPhone

app store icon

Kindle



Orthopedic and Dental Industry News Complete Archive »

Musculoskeletal News Roundup 21-Jan-10 BY LAUREN UZDIENSKI, JANUARY 21, 2010

Earnings
MEDICREA reported 4Q:09 sales of EUR 3.9 million ($5.6 million) and 2009 sales of EUR 13.1 million ($18.8 million), representing a 45% increase over 2008. The company said their sales development in the U.S. has been "successful" and a major source of revenue growth; they also note that most sales came from the PASS-LP thoraco-lumbar fixation system for the reduction of major spinal deformations.

Funding
ProChon Biotech closed a $4.0 million convertible bridge loan from current investors ProChon Holdings B.V. and the Musculoskeletal Transplant Foundation. Proceeds will further the clinical development of the BioCart Cartilage Regeneration System, an ACI product, and U.S. manufacturing of the company’s fibroblast growth factor technology.

Regulatory
On January 22, ArthroCare will resume trading on the NASDAQ under the symbol ARTC.

Oxford Performance Materials and NMB Medical Applications announced that their Quantum Composite Nailing System received CE mark clearance. The radiolucent system is made from Oxford's OXPEKK BioFlex carbon composite material, which offers "enhanced biomechanical properties" and an "elasticity modulus similar to bone."

Product Introduction and Update
Axis Surgical Technologies announced the first human use of C-MOR, a handheld direct-imaging tool designed for use in arthroscopic procedures. The company says their goal is to "enable smaller clinics, practices and field trauma centers to have the direct imaging capabilities currently available in larger facilities."

Clinical
Vertos Medical completed enrollment in a post-market study of its mild procedure, a minimally-invasive decompression treatment for central-canal spinal stenosis. The study enrolled 75 patients across several U.S. sites.

Collaborations
Alphatec Spine, DePuy, Medtronic, Smith & Nephew and Synthes are among the companies contributing money and surgical supplies to Haiti to help victims of the earthquake.

Appointments
Dr. Jeffrey Shuren has been appointed director of the CDRH after serving as its acting director since August 2009. Dr. Shuren has held prior positions at CMS and the FDA, where he was named associate commissioner for policy and planning in 2008.

Email this to a colleague: